OpenBilldrug price receipt

NADAC week of 2026-10-14

BCG (TICE STRAIN) VIAL

FDA nonproprietary name: bacillus calmette-guerin

For 1 unit (EA)

Pharmacies pay

$187.77 filed

1 × $187.77376 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-26 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part B pays

$176.60 derived

1 × $176.60 per EA, Part B limit

Medicare's price is not your price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)


The spread

0.94× derived

Medicare pays 6% less than pharmacies pay.

Derived because only one labeler, Merck Sharp & Dohme LLC, is listed for HCPCS J9030 on the CMS crosswalk, so the payment limit comes from that company’s own products under the code, not an average across companies.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-26 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Cost-plus estimate

$220.94 estimated

$187.77 + $28.17 (15%) + $5.00 fee per fill = $220.94

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-26 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BCG (TICE STRAIN) VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as bacillus calmette-guerin, under the trade name “TICE BCG”.

FDA gives its dosage form as powder, for suspension and its route as intravesical.

The labeler, the company named on the label, is Merck Sharp & Dohme LLC.

FDA lists it under 2 Established Pharmacologic Classes: Live Attenuated Bacillus Calmette-Guerin Immunotherapy and Live Attenuated Bacillus Calmette-Guerin Vaccine.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes); the FDA directory lists 1 of them.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $187.77 for 1 unit (EA) (1 × $187.77376 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-26. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 3, the survey-based NADAC was adjusted for changes in published pricing, or after a help-desk inquiry; 5, calculated based on package size.

All 2 NDCs

What Medicare paid

Medicare Part B’s payment limit for HCPCS J9030, for 2026-10-01 to 2026-12-31, comes to $176.60 for 1 unit (EA), or $176.60 per EA once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.7064 per 1 MG.

1 of the product’s 2 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists 1 of its 2 NDCs (it does not list the other one) as dosage form “POWDER, FOR SUSPENSION” with route “INTRAVESICAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.